Free Trial
NASDAQ:OMIC

Singular Genomics Systems (OMIC) Stock Price, News & Analysis

Singular Genomics Systems logo
$20.01 0.00 (0.00%)
As of 02/21/2025

About Singular Genomics Systems Stock (NASDAQ:OMIC)

Key Stats

Today's Range
$20.01
$20.01
50-Day Range
$20.01
$20.01
52-Week Range
$5.34
$23.41
Volume
N/A
Average Volume
41,211 shs
Market Capitalization
$50.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50
Consensus Rating
Hold

Company Overview

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

Receive OMIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter.

OMIC Stock News Headlines

Singular Genomics highlights G4X milestones at AGBT
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Singular Genomics announces closing of acquisition by Deerfield Managment
Singular Genomics Systems Inc
See More Headlines

OMIC Stock Analysis - Frequently Asked Questions

Singular Genomics Systems' stock was trading at $19.43 on January 1st, 2025. Since then, OMIC stock has increased by 3.0% and is now trading at $20.01.
View the best growth stocks for 2025 here
.

Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($6.72) EPS for the quarter, beating the consensus estimate of ($8.05) by $1.33. The firm had revenue of $0.41 million for the quarter, compared to the consensus estimate of $0.74 million. Singular Genomics Systems had a negative net margin of 3,237.89% and a negative trailing twelve-month return on equity of 57.87%.

Singular Genomics Systems shares reverse split before market open on Wednesday, June 26th 2024. The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Singular Genomics Systems (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO.

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Singular Genomics Systems investors own include NVIDIA (NVDA), Tesla (TSLA), Albemarle (ALB), CrowdStrike (CRWD), Etsy (ETSY), Ford Motor (F) and Fluence Energy (FLNC).

Company Calendar

Last Earnings
11/12/2024
Today
5/02/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:OMIC
Fax
N/A
Employees
220
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.50
High Stock Price Target
$6.50
Low Stock Price Target
$6.50
Potential Upside/Downside
-67.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-94,820,000.00
Net Margins
-3,237.89%
Pretax Margin
-3,237.89%

Debt

Sales & Book Value

Annual Sales
$2.91 million
Price / Cash Flow
N/A
Book Value
$73.25 per share
Price / Book
0.27

Miscellaneous

Free Float
1,974,000
Market Cap
$50.83 million
Optionable
No Data
Beta
1.83
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:OMIC) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners